A group from Brisbane Australia has recently published a high profile clinical trial comparing open and robotic prostate cancer surgery. This trial is the first of its kind, and the implication of its results deserves a closer look.
There has perhaps never been as controversial a test as the PSA (prostate specific antigen). An expert panel including GPs, urologists, public health experts, pathologists, oncologists and allied health professionals have developed new, local and evidence based guidelines for PSA testing. What do they mean for you?